FDA 510(k)

Premarket Notification — US Medical Device Clearance Program

apartmentPublishing Organization:U.S. Food and Drug Administration (FDA)

United States Medical Devices Healthcare Electronics

Standard Introduction

The FDA 510(k) is the most common premarket submission pathway for medical devices in the United States, named after Section 510(k) of the Federal Food, Drug, and Cosmetic Act. A 510(k) clearance demonstrates that a new device is 'substantially equivalent' to a legally marketed predicate device — meaning it has the same intended use and similar technological characteristics, or if different, does not raise new questions of safety and effectiveness. Managed by the FDA's Center for Devices and Radiological Health (CDRH), the 510(k) program covers most Class II medical devices and some Class I devices that are not exempt from premarket notification. Approximately 3,000-4,000 510(k) submissions are reviewed annually.

The 510(k) submission process requires identifying an appropriate predicate device, preparing a comparison showing substantial equivalence, conducting performance testing (biocompatibility, electromagnetic compatibility, software validation, etc.), and submitting the package to FDA. Three types of 510(k) exist: Traditional (most comprehensive), Special (for well-understood device modifications), and Abbreviated (leveraging recognized consensus standards or FDA guidance). The FDA review timeline is typically 90 days from acceptance, though actual clearance often takes 3-12 months including pre-submission interactions. In 2023, FDA introduced the Predetermined Change Control Plan pathway, allowing manufacturers to describe anticipated device modifications in the original submission, reducing the need for future 510(k)s. Key differences from EU MDR include the predicate-based approach (vs. risk-based), generally less clinical data required, and no mandatory quality system certification — though FDA's Quality System Regulation (21 CFR 820) compliance is expected.

compare

Substantial Equivalence

The core of 510(k) — demonstrate your device is substantially equivalent to a legally marketed predicate device in intended use, technology, and performance.

schedule

Average 100-Day Review

FDA targets a 90-day review cycle for Traditional 510(k) submissions. Actual average clearance time is approximately 100 days, not counting RTA hold times.

Three Submission Types

Traditional 510(k) for standard comparisons, Special 510(k) for modifications to your own device, and Abbreviated 510(k) using guidance documents or special controls.

list_alt Key Submission Elements

Predicate device comparison and substantial equivalence argument
Device description and intended use
Performance testing (bench, biocompatibility, software)
Labeling including indications for use
Sterilization validation (if applicable)
Biocompatibility assessment per ISO 10993
Electrical safety and EMC testing (if applicable)
510(k) summary or 510(k) statement

Who Needs to Comply?

groups

Manufacturers of Class II medical devices (and some Class I and Class III devices) intended for the US market. Required before commercially distributing a new device or a device with significant changes to design or intended use.

Key Requirements

Predicate Device Selection

Identify a legally marketed predicate device with the same intended use and similar technological characteristics. The predicate must have a valid 510(k) clearance, pre-amendment status, or De Novo classification.

Substantial Equivalence Testing

Conduct performance testing to demonstrate your device is as safe and effective as the predicate. Testing scope depends on differences — may include bench testing, animal studies, biocompatibility, software validation, and/or clinical data.

Quality System Compliance

Maintain a Quality Management System compliant with 21 CFR Part 820 (Quality System Regulation). FDA may inspect your facility before or after clearance. Design controls are required for Class II devices.

Post-Market Requirements

Register your establishment and list devices with FDA annually. Report adverse events via MDR (Medical Device Reporting). Implement corrections and removals when necessary and report to FDA.

Penalties & Enforcement

warning

Marketing a device without required 510(k) clearance is a violation of the Federal Food, Drug, and Cosmetic Act. FDA can issue Warning Letters, seize products, seek injunctions, and pursue criminal prosecution. Civil monetary penalties up to $17,730 per violation per day.